NCT04403581 |
Egyptian Doctors Stresses Knowledge and Attitude During COVID-19 Pandemic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403568 |
Testing the Synergism of Phytonutrients Curcumin and Ursolic Acid to Target Molecular Pathways in the Prostate |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403555 |
Ivermectin as a Novel Therapy in COVID-19 Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403542 |
Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403529 |
Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403516 |
Dextenza in Pterygium Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403503 |
The Influence of Tissue Adhesive to Palatal Donor Site Healing |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403490 |
Effect of HABIT-ILE on the Body Function and Structures of Children With Cerebral Palsy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403477 |
Convalescent Plasma Therapy in Severe COVID-19 Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403464 |
Effect of a New Interactive Device on the Motor and Functional Abilities of Children With Bilateral Cerebral Palsy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403451 |
True North Healthy Relationships Grant |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403438 |
Familial Mediterranean Fever and Behçet Analysis Before and After Covid19 Pandemic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403425 |
Tissue Perfusion During Emergency Laparotomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403412 |
Changes of Left Atrial Function and Quality of Life in Patients With Left Atrial Appendage Occlusion |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403399 |
Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinsons Disease Project 3 - Experiment 3 UdallP3E3 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403386 |
Prospective Natural History Study of Smoking Immune Cell Profiles Epigenetics and COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403373 |
Effectiveness of Walking Exercise in Improving Depression in Older Adults With Major Depressive Disorder A Pilot Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403360 |
Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403347 |
Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403334 |
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403321 |
Efficacy and Safety of Eltrombopag Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403308 |
ONO-7913 Phase I Study ONO-7913 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403295 |
Collaborative Specialty Care for Gulf War Illness |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403282 |
Topical Eflornithine for Pseudofolliculitis Barbae Randomized Controlled Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403269 |
NORMAL HUMAN IMMUNOGLOBULINS IVIG IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403256 |
Bone-biomarkers of Spinal Cord Injury Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403243 |
COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403230 |
Outcomes on Teeth Prepared With BOPT |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403217 |
Effect of MEDiterranean Diet on the microBIOME of Individuals With Type 2 Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403204 |
ICG Fluorescence Imaging in Post-traumatic Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403191 |
Usage of Multiple Drugs in Treatment of Postoperative Vomiting After Laparoscopic Appendectomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403178 |
Prevention of Hip Displacement in Children With Cerebral Palsy in Denmark |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403165 |
Locus-coeruleus Function in Normal Elderly and AD Risk |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403152 |
Postoperative Rehabilitation or Mobilization After Scoliosis Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403139 |
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403126 |
To Increase Psychological Well-being by the Implementation of Forgiveness Education |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403113 |
The Effects of Neurodevelopmental Therapy on Feeding and Swallowing |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403100 |
Hydroxychloroquine and Lopinavir Ritonavir to Improve the Health of People With COVID-19 The Hope Coalition - 1 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403087 |
Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403074 |
Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis EUS-CPN for Chronic Pancreatitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403061 |
Th1Th2Th17TREG and TLRs ActivationKIR for COVID 19 Prediction of Outcome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403048 |
Drug Coated Balloon for Side Branch Treatment vs Conventional Approach in True Bifurcation Coronary Disease PRO-DAVID |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403035 |
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403022 |
da Vinci SP Investigational Device Exemption Study in Colorectal Procedures |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04403009 |
The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402996 |
Meteorin-like Levels in Individuals With Periodontitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402983 |
The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402970 |
Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 SARS-CoV-2 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402957 |
LSALT Peptide vs Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402944 |
Pulmozyme to Improve COVID-19 ARDS Outcomes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402931 |
Randomized Trial of Transcatheter Valve-in-Valve vs Redo Surgery for Bioprosthetic Mitral Dysfunction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402918 |
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 COVID-19 During Pregnancy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402905 |
Observational Study in Diagnosed Patients COVID-19 Supported on an Outpatient Basis COVID-PSL |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402892 |
COVID-19 SARS-CoV-2 Specific Memory B and T-CD4 Cells |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402879 |
CORONA COvid pRONe hypoxemiA Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402866 |
TD-0903 for ALI Associated With COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402853 |
SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402840 |
Stellate Ganglion Block SGB for COVID-19 Acute Respiratory Distress Syndrome ARDS |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402827 |
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402814 |
IgGIgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402801 |
Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402788 |
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment Atezolizumab for Extensive Stage Small Cell Lung Cancer The RAPTOR Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402775 |
Brachiocephalic Arteriovenous Fistulae Two Different Techniques of Bloodless Surgery and Their Effect on Fistula Stenosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402762 |
Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402749 |
The Incidence of Pulmonary Embolism During Nephrectomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402736 |
Feasibility and Effectiveness of Rehabilitation Nursing for Acute Stroke |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402723 |
Combination of Donafenib and CytarabineDaunorubicin in Relapsed AML |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402710 |
Is Teaching People to be Self-compassionate Feasible and Acceptable for People Who Are Pre-diabetic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402697 |
Analysis of Metabolic State in Normal-weight and Overweight-obese After Lifestyle Improvement andor Weight Loss |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402684 |
Influenza Vaccination in Patients Living With HIV in the Northern Region |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402671 |
Lateral Ridge Augmentation Using Cross-linked or Non-cross-linked Collagen Membrane |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402658 |
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402645 |
Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402632 |
Embolization of the Middle Meningeal Artery with ONYX Liquid Embolic System for Subacute and Chronic Subdural Hematoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402619 |
Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402606 |
Study on Skin Toxicities Induced by Cancer Treatments |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402593 |
Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC A Pilot Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402580 |
Efficacy of Anti-CD20 Antibodies Rituximab Biosimilar in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402567 |
Impact and Burden of Rugby Injuries in Argentina A Complete Season Retrospective Multicentric Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402554 |
Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402541 |
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402528 |
Preschool ADHD On-line Behavioral Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402515 |
Tiotropium Plus Olodaterol vs Inhaled Corticosteroids ICS Regimens in the Portuguese Primary Care Setting TIOLCOR Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402502 |
Dynamic 4DCT to Examine Wrist Carpal Mechanics |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402489 |
Study to Evaluate Efficacy Safety and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402476 |
Skin Sensitisation Modified Draize-95 Test |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402463 |
Effects of Global Postural Exercises Versus Specific Therapeutic Neck Exercises in Chronic Non-specific Neck Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402450 |
Suprainguinal Fascia Iliaca Block Versus PENG Block for Hip Arthroplasty Analgesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402437 |
QL vs LP Blocks for Analgesia Following THA |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402424 |
Point of Care Faecal Immunochemical Testing for Colorectal Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402411 |
Quadratus Lumborum Block vs Transversus Abdominis Plane Block in Bladder Cancer Surgeries |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402398 |
Psychometric Properties of a Mobile Application |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402385 |
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension ASPPIRE |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402372 |
Novel Bidirectional Peripheral Artery Cannula in Minimally Invasive Aortic Valve Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402359 |
Usage of MeropenemGentamicin Versus CeftazidimeAvibactam in ARDS |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402346 |
Radiofrequency-assisted Transection of the Pancreas vs Stapler |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402333 |
Minimally Invasive Robotic Surgery Role in Optimal Debulking Ovarian Cancer Recovery Survival |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402320 |
Non Invasive and Invasive Ventilation Post Extubation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402307 |
Effect of Training of Patients With Dysphagia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402294 |
Individualized Closed Loop TMS for Working Memory Enhancement |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402281 |
Use of suPAR Algorithm for the ED Decision Making |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402268 |
Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402255 |
Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402242 |
Impact of NOL Index Intraoperative Guided Remifentanil Analgesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402229 |
Psychological Impact of the Covid-19 Pandemic on Student Nurses |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402216 |
Using Virtual Reality Simulation to Prepare Children Undergoing MRI |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402203 |
Study on Safety and Efficacy of Favipiravir Favipira for COVID-19 Patient in Selected Hospitals of Bangladesh |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402190 |
Hypotonic Hyponatremia Criteria for the Correct Classification of Its Etiology and of Patient Volume Status |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402177 |
This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402164 |
Skeletally Versus Dentally Anchored Herbst Appliance |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402151 |
Study of PSMA PETMR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost SBRT-SIB for High-Intermediate and High Risk Prostate Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402138 |
Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402125 |
Reducing Stroke Risk in African-American Men |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402112 |
Efficacy and Safety of Pitavastatin in a Real-world Setting |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402099 |
Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer PLC Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402086 |
Rheumatology Patient Registry and Biorepository |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402073 |
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402060 |
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402047 |
Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402034 |
Telerehabilitation in Disabled People Proposal for Practical Intervention With Virtual Reality |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402021 |
Exercise and Insomnia Study The Effects of 1 Week of Exercise Training on Insomnia Severity |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04402008 |
Study of Poziotinib in Japanese Patients With NSCLC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401995 |
Study of TLR9 Agonist Vidutolimod CMP-001 in Combination with Nivolumab Vs Nivolumab |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401982 |
Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401969 |
Tissue Microenvironment Signatures of the Mycetoma Granuloma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401956 |
Bread Study Comparison of the Tolerance of Spelt and Wheat Bread |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401943 |
Online Fatigue Intervention Program for People With Scleroderma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401930 |
Eating Habits and Lifestyle Profile of an Italian Aging Cohort |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401917 |
Evaluation of Neuroinflammation FNOS PETCT in HIV and - Subjects With OUD and Healthy Controls |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401904 |
SGLT2 Inhibition in Older Obese Adults With Pre-diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401891 |
Formal Pre-Operative Education |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401878 |
SGB in Management of Patients With PDPH Using TCD |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401865 |
Safety and Effectiveness of the PXL-Platinum 330 System |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401852 |
Magnesium Sulfate for Fetal Neuroprotection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401839 |
Amr Maneuver for Prevention of Postpartum Hemorrhage |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401826 |
Micro-surgical Treatment of Gummy Smile |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401813 |
Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular Carcinoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401800 |
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401787 |
Converted Laparoscopic Resection of Upper Rectal Carcinoma T1-4 N0-1 in Obese Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401774 |
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401761 |
A Study to Collect Data on the Treatment Pattern of Xarelto Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and or a Condition That Most Commonly Narrows the Blood Vessel in the Legs |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401748 |
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401735 |
Effects and Safety of Epidural PDRN vs Placebo |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401722 |
Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401709 |
Gemcitabine Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401696 |
Effectiveness of Bubble Nasal Continuous Positive Airway Pressure bCPAP in Neonatal Respiratory Distress |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401683 |
Home-based Exercise Rehabilitation With a Novel Digital Biofeedback System for Chronic Low Back Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401670 |
Cervical Cancer Screening in Cameroon |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401657 |
FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401644 |
COVID-19 Laser Interferometry for Rapid Single Coronavirus Detection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401631 |
Analytical Validation of the abioSCOPE Device With an IgE Test Panel Point-of-Care Precision Sample Type Comparison and Method Correlation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401618 |
Retrospective Evaluation of RMGIGI Class V Restorations |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401605 |
Fermented Food-Supplemented Diet in Ulcerative Colitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401592 |
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401579 |
Adaptive COVID-19 Treatment Trial 2 ACTT-2 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401566 |
Investigation of Acute Effects of Myofascial Trigger Point Release in Women With Chronic Pelvic Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401553 |
Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401540 |
Characteristics of Neonatal Covid-19 in Turkey |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401527 |
Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401514 |
Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401501 |
Effects of Manual Therapy on the Upper Cervical Spine Combined With Exercise vs Isolated Exercise in Patients With Cervicogenic Headache |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401488 |
Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401475 |
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 SOC vs Placebo SOC in Adult Hospitalized Patients With COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401462 |
Scandinavian Olecranon Research in the Elderly |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401449 |
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401436 |
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401423 |
TXA127 for the Treatment of Severe COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401410 |
Anti-SARS Cov-2 T Cell Infusions for COVID 19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401397 |
Effect of Early Mobilization on Length of Stay Recovery and Readmission Rate of Patients After CABG or AVRMVR Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401384 |
Effectiveness of Acupuncture and DoxylaminePyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401371 |
Distance and Hybrid Learning for Dental Student During COVID-19 Pandemic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401358 |
Smell Taste Salivary Flow and Oral Health in Patient Receiving Dialysis A Before and After Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401345 |
Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401332 |
A Randomized Controlled Trial of AppS to Home Monitor Your Asthma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401319 |
rTMS and EEG in DOC Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401306 |
Remote Training in Laparoscopy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401293 |
Full Dose Heparin Vs Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401280 |
Bioactive Glass in the Treatment of Enamel White Spot Lesions |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401267 |
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic LeukemiaLymphoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401254 |
Recovery of Patients From COVID-19 After Critical Illness |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401241 |
How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401228 |
Predictive Models for Intensive Care Admission and Death of COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401215 |
Technologically-Augmented Referrals to Mitigate Addiction Consequences |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401202 |
Nigella Sativa in COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401189 |
The Role of Circadian Rhythms in Cancer-Related Symptoms |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401176 |
Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial CystitisBladder Pain Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401163 |
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401150 |
Lessening Organ Dysfunction With VITamin C - COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401137 |
The Evaluation of PharmacokineticPharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401124 |
Status of Management of Surgery in Beijing During COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401111 |
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia CO-Qo-ICU |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401098 |
Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401085 |
COVID-19 Herd Immunity Study in the Czech Republic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401072 |
Attitude of Egyptian Population Toward COVID 19 in Ramadan |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401059 |
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLCProspective Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401046 |
COVID-19 and Reorganisation of Cancer Patient Care Self- Evaluation of Potential Post-traumatic Stress Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401033 |
Increased Risk of SARS-CoronaVirus-2 SARS-CoV-2 Infection Associated With Endoscopy DECORE Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401020 |
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04401007 |
Erector Spinae Plane ESP Block Volunteer Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04400994 |
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|